Cargando…

Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial

BACKGROUND: Nuclear magnetic resonance (NMR) imaging and spectroscopy have been applied to assess skeletal muscle oxidative metabolism. Therefore, in-vivo NMR may enable the characterization of ischemia-reperfusion injury. The goal of this study was to evaluate whether NMR could detect the effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreas, Martin, Schmid, Albrecht I, Keilani, Mohammad, Doberer, Daniel, Bartko, Johann, Crevenna, Richard, Moser, Ewald, Wolzt, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143996/
https://www.ncbi.nlm.nih.gov/pubmed/21718491
http://dx.doi.org/10.1186/1532-429X-13-32
_version_ 1782208963733880832
author Andreas, Martin
Schmid, Albrecht I
Keilani, Mohammad
Doberer, Daniel
Bartko, Johann
Crevenna, Richard
Moser, Ewald
Wolzt, Michael
author_facet Andreas, Martin
Schmid, Albrecht I
Keilani, Mohammad
Doberer, Daniel
Bartko, Johann
Crevenna, Richard
Moser, Ewald
Wolzt, Michael
author_sort Andreas, Martin
collection PubMed
description BACKGROUND: Nuclear magnetic resonance (NMR) imaging and spectroscopy have been applied to assess skeletal muscle oxidative metabolism. Therefore, in-vivo NMR may enable the characterization of ischemia-reperfusion injury. The goal of this study was to evaluate whether NMR could detect the effects of ischemic preconditioning (IPC) in healthy subjects. METHODS: Twenty-three participants were included in two randomized crossover protocols in which the effects of IPC were measured by NMR and muscle force assessments. Leg ischemia was administered for 20 minutes with or without a subsequent impaired reperfusion for 5 minutes (stenosis model). IPC was administered 4 or 48 hours prior to ischemia. Changes in (31)phosphate NMR spectroscopy and blood oxygen level-dependent (BOLD) signals were recorded. 3-Tesla NMR data were compared to those obtained for isometric muscular strength. RESULTS: The phosphocreatine (PCr) signal decreased robustly during ischemia and recovered rapidly during reperfusion. In contrast to PCr, the recovery of muscular strength was slow. During post-ischemic stenosis, PCr increased only slightly. The BOLD signal intensity decreased during ischemia, ischemic exercise and post-ischemic stenosis but increased during hyperemic reperfusion. IPC 4 hours prior to ischemia significantly increased the maximal PCr reperfusion signal and mitigated the peak BOLD signal during reperfusion. CONCLUSIONS: Ischemic preconditioning positively influenced muscle metabolism during reperfusion; this resulted in an increase in PCr production and higher oxygen consumption, thereby mitigating the peak BOLD signal. In addition, an impairment of energy replenishment during the low-flow reperfusion was detected in this model. Thus, functional NMR is capable of characterizing changes in reperfusion and in therapeutic interventions in vivo. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00883467
format Online
Article
Text
id pubmed-3143996
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31439962011-07-27 Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial Andreas, Martin Schmid, Albrecht I Keilani, Mohammad Doberer, Daniel Bartko, Johann Crevenna, Richard Moser, Ewald Wolzt, Michael J Cardiovasc Magn Reson Research BACKGROUND: Nuclear magnetic resonance (NMR) imaging and spectroscopy have been applied to assess skeletal muscle oxidative metabolism. Therefore, in-vivo NMR may enable the characterization of ischemia-reperfusion injury. The goal of this study was to evaluate whether NMR could detect the effects of ischemic preconditioning (IPC) in healthy subjects. METHODS: Twenty-three participants were included in two randomized crossover protocols in which the effects of IPC were measured by NMR and muscle force assessments. Leg ischemia was administered for 20 minutes with or without a subsequent impaired reperfusion for 5 minutes (stenosis model). IPC was administered 4 or 48 hours prior to ischemia. Changes in (31)phosphate NMR spectroscopy and blood oxygen level-dependent (BOLD) signals were recorded. 3-Tesla NMR data were compared to those obtained for isometric muscular strength. RESULTS: The phosphocreatine (PCr) signal decreased robustly during ischemia and recovered rapidly during reperfusion. In contrast to PCr, the recovery of muscular strength was slow. During post-ischemic stenosis, PCr increased only slightly. The BOLD signal intensity decreased during ischemia, ischemic exercise and post-ischemic stenosis but increased during hyperemic reperfusion. IPC 4 hours prior to ischemia significantly increased the maximal PCr reperfusion signal and mitigated the peak BOLD signal during reperfusion. CONCLUSIONS: Ischemic preconditioning positively influenced muscle metabolism during reperfusion; this resulted in an increase in PCr production and higher oxygen consumption, thereby mitigating the peak BOLD signal. In addition, an impairment of energy replenishment during the low-flow reperfusion was detected in this model. Thus, functional NMR is capable of characterizing changes in reperfusion and in therapeutic interventions in vivo. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00883467 BioMed Central 2011-06-30 /pmc/articles/PMC3143996/ /pubmed/21718491 http://dx.doi.org/10.1186/1532-429X-13-32 Text en Copyright ©2011 Andreas et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Andreas, Martin
Schmid, Albrecht I
Keilani, Mohammad
Doberer, Daniel
Bartko, Johann
Crevenna, Richard
Moser, Ewald
Wolzt, Michael
Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial
title Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial
title_full Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial
title_fullStr Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial
title_full_unstemmed Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial
title_short Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial
title_sort effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143996/
https://www.ncbi.nlm.nih.gov/pubmed/21718491
http://dx.doi.org/10.1186/1532-429X-13-32
work_keys_str_mv AT andreasmartin effectofischemicpreconditioninginskeletalmusclemeasuredbyfunctionalmagneticresonanceimagingandspectroscopyarandomizedcrossovertrial
AT schmidalbrechti effectofischemicpreconditioninginskeletalmusclemeasuredbyfunctionalmagneticresonanceimagingandspectroscopyarandomizedcrossovertrial
AT keilanimohammad effectofischemicpreconditioninginskeletalmusclemeasuredbyfunctionalmagneticresonanceimagingandspectroscopyarandomizedcrossovertrial
AT dobererdaniel effectofischemicpreconditioninginskeletalmusclemeasuredbyfunctionalmagneticresonanceimagingandspectroscopyarandomizedcrossovertrial
AT bartkojohann effectofischemicpreconditioninginskeletalmusclemeasuredbyfunctionalmagneticresonanceimagingandspectroscopyarandomizedcrossovertrial
AT crevennarichard effectofischemicpreconditioninginskeletalmusclemeasuredbyfunctionalmagneticresonanceimagingandspectroscopyarandomizedcrossovertrial
AT moserewald effectofischemicpreconditioninginskeletalmusclemeasuredbyfunctionalmagneticresonanceimagingandspectroscopyarandomizedcrossovertrial
AT wolztmichael effectofischemicpreconditioninginskeletalmusclemeasuredbyfunctionalmagneticresonanceimagingandspectroscopyarandomizedcrossovertrial